Cancer Survivor Wins Top Science Award, Targets New Treatments

A distance runner who could run a sub-five-minute mile suddenly couldn't walk upstairs without losing her breath. When 18-year-old Elise Boyse got her X-ray results in December of her senior year, she saw the answer in her parents' faces before they said a word.

The mass in her chest turned out to be Hodgkin's lymphoma. Four months of chemotherapy followed, stealing her hair and energy but never her determination to finish high school or her passion for chemistry.

"I was able to maintain a level of normalcy that I know would not have been possible decades ago," Boyse said. That gratitude sparked a mission: help make cancer treatment even better for those who come after her.

Now a junior at Davidson College, Boyse has won a 2026 Goldwater Scholarship, one of the nation's most prestigious awards in science and mathematics. She was selected from 1,485 nominees as someone likely to become a leading researcher in her field.

Her focus? A protein that both spreads and suppresses cancer, which could lead to targeted immunotherapies that save lives while reducing the brutal side effects she experienced firsthand.

Chemistry Professor Nicole Snyder noticed Boyse's exceptional talent from day one. The first-year student asked questions that pushed beyond the classroom into genuine scientific inquiry, mastering complex material with unusual intellectual maturity.

"She has the ability to bridge theory and experiment, synthesize complex literature into actionable research plans, and contribute meaningfully to projects with real translational impact," Snyder said.

When Boyse arrived at Davidson after finishing chemotherapy, she wore a wig to cover her hair loss and struggled to regain her running fitness. She'd worried her athletic scholarship might be rescinded, but track coach Jen Straub assured her family it was never in question.

Why This Inspires

Boyse represents a powerful shift in cancer treatment and survivorship. She experienced therapies that would have been impossible just decades ago, allowing her to attend class and even race during chemotherapy.

Now she's using that very survival as fuel to make the next generation of treatments even gentler and more effective. Her research isn't abstract; it's personal, informed by every exhausting treatment session and every moment she felt grateful for her doctors' care.

The teenager who peppered her radiologist father and dermatologist mother with endless "how does this work?" questions has found the puzzle she was meant to solve.

Her work could help future patients maintain even more normalcy during treatment, attend more classes, run more races, and return to their lives faster than she did. And Boyse is just getting started.